TABLE 3.
Event rate comparison between aspirin sensitive and aspirin nonsensitive patients
| Event | Aspirin sensitive (n = 114) | Aspirin nonsensitive (n = 36) | P value |
|---|---|---|---|
| MI | 2 (2) | 4 (11) | .03* |
| Stroke | 2 (2) | 3 (8) | .09 |
| CLTI | 12 (11) | 12 (33) | .003* |
| Limb amputation | 2 (2) | 2 (6) | .24 |
| Cardiovascular related death | 0 (0) | 0 (0) | NA |
| MACE | 4 (4) | 7 (19) | .004* |
| MALE | 14 (12) | 14 (39) | .001* |
| MACE and/or MALE | 18 (16) | 21 (58) | .001* |
Variables are shown in number (percent).
Abbreviations: CLTI, chronic limb‐threatening ischemia; MACE, major adverse cardiovascular event; MALE, major adverse limb event; MI, myocardial infarction.
*Represents significant difference between aspirin‐sensitive and aspirin‐nonsensitive patients; P <.05; differences between groups were compared using Fisher’s exact test.